BIO Europe Autumn 2023

  6-8 November

 Munich, Germany

PrecisionLife is attending BIO Europe Autumn 2023 to hold partnering meetings with biopharma companies innovating to develop better treatments for chronic diseases with unmet medical needs.

Joining the event from PrecisionLife will be:

• Rowan Gardner, Chief Business & Investment Officer
• Gianluca Valenza, Business Development Director

Login to the BIO Europe partneringONE platform to connect with Rowan and Gianluca or contact us to request a meeting.

PrecisionLife focuses on precision medicine analytics in complex chronic diseases, including autoimmune, cardiovascular, respiratory and metabolic diseases. We have multiple pharma precision neuroscience strategic R&D collaborations, and have generated deep disease insights in 50 diseases. 

We map novel targets to specific patient subgroups with causal genetic and mechanistic explanations and disease prelevance. Our patient stratification biomarkers help design smaller, faster, more targeted clinical trials and to build highly predictive complementary diagnostics. We also work with biopharma companies to reevaluate clinical trial results, identify secondary indications and out-licensing opportunities for pipeline and/or stalled assets.